TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -3 | 3 | -1 | -31 | -48 | -60 | -23 |
| S | %wins | 100 | 67 | 67 | 67 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/25/15 16:09 | 11/23/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | S.d | -450 | 18.00 | 33 | -25 | -42 | 35 | D | -37 | -15 | -39 | 24 | 32 | 36 | 25 | 23 | 0 | -1 | -8 | -58 | -77 | -76 |
6/16/15 16:19 | 6/15/15 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | NJ | O | SVP,CFO | S.d | -615 | 24.59 | 33 | -25 | -50 | 25 | D | 54 | 44 | 36 | -20 | -2 | -11 | -6 | -3 | -1 | 9 | 9 | -37 | -41 | -82 |
12/10/13 16:15 | 12/6/13 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Catlin Avery W | MA | O | SVP,CFO | S.d | -4,492 | 24.50 | 33 | -183 | -93 | 14 | D | 751 | 342 | 57 | -1 | 4 | 1 | -11 | -7 | -7 | 0 | -3 | 3 | -26 | -22 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |